Literature DB >> 24807824

Age and activation determines the anticonvulsant effect of ifenprodil in rats.

Pavel Mareš1.   

Abstract

Ifenprodil, an antagonist of NMDA receptors containing the NR2B subunit, was expected to exhibit anticonvulsant action in rat pups up to the third postnatal week because of predominance of NR2B subunit at early development. Cortical epileptic afterdischarges (ADs) were used to study possible effects on threshold current intensities and duration of ADs in 12-, 15-, 18-, and 25-day-old rats. A series of 18 stimulation series with stepwise increasing current intensities (from 0.2 to 15 mA) was applied with 10-min intervals. The first experiment studied rats pretreated with ifenprodil (20 or 40 mg/kg), the second experiment studied an effect of ifenprodil on already present ADs-the dose of 20 mg/kg was administered after stimulation with the 3.5-mA current intensity. Pretreatment with ifenprodil resulted in an anticonvulsant effect in 15-day-old rats only, on the contrary, proconvulsant action was found in 18- and 25-day-old animals (decrease of thresholds especially for transition into the second, limbic type of ADs and increase in duration of ADs). Anticonvulsant effect was found in 12-, 15-, and 18-day-old rats in the second experiment-ADs were shortened. In contrast, no effect was observed in 25-day-old animals. An anticonvulsant action of ifenprodil is not only age-dependent but also activation-dependent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807824     DOI: 10.1007/s00210-014-0987-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

Review 1.  Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research.

Authors:  Ann Li Lim; David Alan Taylor; Daniel Thomas Malone
Journal:  Behav Brain Res       Date:  2011-11-09       Impact factor: 3.332

Review 2.  The NMDA receptor complex as a therapeutic target in epilepsy: a review.

Authors:  Mehdi Ghasemi; Steven C Schachter
Journal:  Epilepsy Behav       Date:  2011-11-04       Impact factor: 2.937

Review 3.  NMDA receptors and learning and memory processes.

Authors:  C Castellano; V Cestari; A Ciamei
Journal:  Curr Drug Targets       Date:  2001-09       Impact factor: 3.465

4.  Influence of clonazepam on cortical epileptic afterdischarges in rats.

Authors:  H Kubová; V Makal; M Minová; S Vanková; P Mares
Journal:  Arch Int Pharmacodyn Ther       Date:  1990 Sep-Oct

5.  A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones.

Authors:  J N Kew; G Trube; J A Kemp
Journal:  J Physiol       Date:  1996-12-15       Impact factor: 5.182

6.  Developmental changes of ketamine action against epileptic afterdischarges induced by hippocampal stimulation in rats.

Authors:  R Mikolásová; L Velísek; J Vorlícek; P Mares
Journal:  Brain Res Dev Brain Res       Date:  1994-08-12

7.  NMDA receptor antagonists impair motor performance in immature rats.

Authors:  A Mikulecká; P Mares
Journal:  Psychopharmacology (Berl)       Date:  2002-06-25       Impact factor: 4.530

Review 8.  Excitatory aminoacids and epileptic seizures in immature brain.

Authors:  P Mares; J Folbergrová; H Kubová
Journal:  Physiol Res       Date:  2004       Impact factor: 1.881

9.  Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections.

Authors:  R A Browning; D K Nelson
Journal:  Exp Neurol       Date:  1986-09       Impact factor: 5.330

10.  N-methyl-D-aspartate receptor antagonists and channel blockers have different effects upon a spinal seizure model in mice.

Authors:  K H McAllister
Journal:  Eur J Pharmacol       Date:  1992-01-28       Impact factor: 4.432

View more
  2 in total

1.  Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome.

Authors:  Stéphane Auvin; Blandine Dozières-Puyravel; Andreja Avbersek; David Sciberras; Jo Collier; Karine Leclercq; Pavel Mares; Rafal M Kaminski; Pierandrea Muglia
Journal:  Ann Clin Transl Neurol       Date:  2020-02-27       Impact factor: 4.511

2.  Anticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats.

Authors:  Pavel Mares; Grygoriy Tsenov; Hana Kubova
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.